Subclass distribution of maternal and neonatal Anti-Ro(SSA) and La(SSB) antibodies in congenital heart block

被引:0
|
作者
Tseng, CE [1 ]
Caldwell, K [1 ]
Feit, S [1 ]
Chan, EKL [1 ]
Buyon, JP [1 ]
机构
[1] SCRIPPS RES INST, DEPT MOLEC & EXPTL MED, WM KECK AUTOIMMUNE DIS CTR, LA JOLLA, CA USA
关键词
anti-Ro(SSA) antibodies; subclass distribution; neonatal lupus; anti-La(SSB) antibodies; congenital heart block;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To compare the subclass distribution of anti-48 kDa La(SSB) and anti-52 and 60 kDa Ro(SSA) antibodies in the maternal and neonatal circulation, in pregnancies affected and unaffected by the development of congenital heart block (CHB). Methods. Sera were obtained from 32 mothers (during 34 pregnancies, 23 complicated by CHB and 11 healthy) demonstrated to have anti-Ro(SSA) and/or La(SSB). Maternal and neonatal autoantibodies were evaluated for subclass distribution by ELISA. Results. All 4 subclasses of anti-Ro(SSA) and La(SSB) antibodies cross the placenta and are detectable in sera obtained from the umbilical cord. IgG1 and IgG3 were the major subclasses represented in the 48 kDa La(SSB) and 52 kDa Ro(SSA) responses. All subclasses, including IgG2 and IgG4, were observed in about one-third of the anti-52 kDa Ro(SSA) and 48 kDaLa(SSB) responses. In contrast, anti-60 kDa antibodies were, with rare exception, confined to IgG1. Except for anti-48 kDa La(SSB) IgG3 antibodies, no significant differences were observed between affected and unaffected pregnancies in the ratio of maternal to neonatal levels of any of the antibody subclasses. Overall, there were no significant differences in the subclass profiles between mothers whose children had heart block and those who did not. Conclusion. The IgG subclasses of anti-48 kDa La(SSB) and anti-52 and 60 kDa Ro(SSA) do not account for the susceptibility of one fetus versus another for the development of CHB. Anti-60 kDa Ro(SSA) antibodies are more restricted in subclass distribution than anti-52 kDa Ro(SSA) or 48 kDa La(SSB) responses.
引用
收藏
页码:925 / 932
页数:8
相关论文
共 50 条
  • [41] Stability of immunoblot profile of anti-SSA/Ro-SSB/La antibodies over time in mothers whose children have neonatal lupus
    Tseng, CE
    DiDonato, F
    Buyon, JP
    LUPUS, 1996, 5 (03) : 212 - 215
  • [42] Early Diagnosis and Treatment of Atrioventricular Block in the Fetus Exposed to Maternal Anti-SSA/Ro-SSB/La Antibodies A Prospective, Observational, Fetal Kinetocardiogram-Based Study
    Rein, A. J. J. T.
    Mevorach, D.
    Perles, Z.
    Gavri, S.
    Nadjari, M.
    Nir, A.
    Elchalal, U.
    CIRCULATION, 2009, 119 (14) : 1867 - 1872
  • [43] Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block
    Mevorach, Dror
    Elchalal, Uriel
    Rein, Azaria J. J. T.
    CURRENT OPINION IN RHEUMATOLOGY, 2009, 21 (05) : 478 - 482
  • [44] Doppler fetal mechanical PR interval prolongation with positive maternal anti-RNP but negative SSA/Ro and SSB/La auto-antibodies
    Acherman, Ruben J.
    Friedman, Deborah M.
    Buyon, Jill P.
    Schwartz, Joel
    Castillo, William J.
    Rollins, Robert C.
    Evans, William N.
    PRENATAL DIAGNOSIS, 2010, 30 (08) : 797 - 799
  • [45] Low titer, isolated anti Ro/SSA 60 kd antibodies is correlated with positive pregnancy outcomes in women at risk of congenital heart block
    Tonello, Marta
    Hoxha, Ariela
    Mattia, Elena
    Zambon, Alessandra
    Visentin, Silvia
    Cerutti, Alessia
    Ghirardello, Anna
    Milanesi, Ornella
    Ruffatti, Amelia
    CLINICAL RHEUMATOLOGY, 2017, 36 (05) : 1155 - 1160
  • [46] Identification and management of fetuses at risk for, or affected by, congenital heart block associated with autoantibodies to SSA (Ro), SSB (La), or an HsEg5-like autoantigen
    Renate Claus
    Heiko Hickstein
    Thomas Külz
    Ute Lenschow
    Doris Meiske
    Andrea Kotitschke
    Hans-Jürgen Thiesen
    Peter Lorenz
    Rheumatology International, 2006, 26 : 886 - 895
  • [47] Identification and management of fetuses at risk for, or affected by, congenital heart block associated with autoantibodies to SSA (Ro), SSB (La), or an HsEg5-like autoantigen
    Claus, Renate
    Hickstein, Heiko
    Kuelz, Thomas
    Lenschow, Ute
    Meiske, Doris
    Kotitschke, Andrea
    Thiesen, Hans-Juergen
    Lorenz, Peter
    RHEUMATOLOGY INTERNATIONAL, 2006, 26 (10) : 886 - 895
  • [48] Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers
    Izmirly, Peter
    Kim, Mimi
    Friedman, Deborah M.
    Costedoat-Chalumeau, Nathalie
    Clancy, Robert
    Copel, Joshua A.
    Phoon, Colin K. L.
    Cuneo, Bettina F.
    Cohen, Rebecca E.
    Robins, Kimberly
    Masson, Mala
    Wainwright, Benjamin J.
    Zahr, Noel
    Saxena, Amit
    Buyon, Jill P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (03) : 292 - 302
  • [49] Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies
    Askanase, AD
    Friedman, DM
    Copel, J
    Dische, MR
    Dubin, A
    Starc, TJ
    Katholi, MC
    Buyon, JP
    LUPUS, 2002, 11 (03) : 145 - 151
  • [50] Anti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options
    Nathalie Costedoat-Chalumeau
    Zahir Amoura
    Elisabeth Villain
    Laurence Cohen
    Jean-Charles Piette
    Arthritis Res Ther, 7